Oncology

A Wealth of Experience

We have collaborated with our clients on projects to research cancer, cancer treatment, and complications and comorbidities of cancer. Our experience includes:

  • Basal cell carcinoma
  • Bladder cancer
  • Breast cancer
  • Cervical cancer
  • Colorectal cancer
  • Endometrial cancer
  • Gastric cancer
  • Glioblastoma multiforme
  • Head and neck cancer
  • Large B-cell lymphoma
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Melanoma
  • Myelofibrosis
  • Neuroendocrine tumors
  • Non-Hodgkin’s lymphoma
  • Renal cell carcinoma
  • Osteosarcoma
  • Ovarian cancer
  • Pancreatic cancer
  • Peritoneal cancers
  • Prostate cancer
  • Thyroid cancer

Types of Projects

We have implemented studies to help our clients develop strategies in the oncology market and to develop and gain 
market access for products to treat cancer and complications arising from treatment of cancer illnesses. 

Recent projects have included:

Our Experts

Carol Mansfield
Senior Research Economist
Mark Price
Senior Director, Surveys and Observational Studies
Beth Sherrill
Vice President, Biostatistics
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Colleen Castro
Senior Associate, Market Access and Outcomes Strategy
Marco Boeri
Senior Research Economist
Shahnaz Khan
Senior Director, Market Access and Outcomes Strategy
Melissa Juniper
Senior Director, Market Access and Outcomes Strategy
Ann Colosia
Associate Director, Market Access and Outcomes Strategy
Keith Davis
Senior Director, Health Economics
Will Herring
Director, Health Economics
Lori McLeod
Head, Psychometrics & Executive Director, Patient-Centered Outcomes Assessment
Costel Chirila
Director, Biostatistics
Anita Brogan
Head, Decision Analytic Modeling, US Health Economics
Christine Poulos
Senior Research Economist
Katherine Houghton
Director, Health Economics
James Kaye
Senior Director, Epidemiology
Annete Njue
Director, Market Access and Outcomes Strategy
Shaun Abeysinghe
Senior Director, Data Analytics and Design Strategy
Ryan Ziemiecki
Director, Biostatistics
Christopher Knight
Senior Director, Health Economics
Jessica Costello
Writer, Market Access and Outcomes Strategy
Kenneth Rothman
Distinguished Fellow, Vice President of Epidemiology Research
Michele Wilson
Director, Health Economics
Juliana Meyers
Director, Health Economics
Lia Gutierrez
Director, Epidemiology
Alicia Gilsenan
Senior Director, Epidemiology
Sorrel Wolowacz
Head, European Health Economics
Elizabeth Andrews
Vice President, Pharmacoepidemiology and Risk Management
Jianmin Wang
Director, Biostatistics, US
Isobel Pearson
Director, Health Economics, Health Technology Assessment
Marci Clark
Director, Patient-Centered Outcomes Assessment
Brett Hauber
Senior Economist and VP, Health Preference Assessment
Dee Dee Mladsi
Head, Health Economics-Strategy and Early Modeling
Xiaolei Zhou
Director, Biostatistics, US
Bintu Sherif
Director, Biostatistics
Caroline Ling
Senior Director, Market Access and Outcomes Strategy
Sean Candrilli
Head, Health Economics
Ewa Rupniewska
Senior Associate, Market Access and Outcomes Strategy
Jin Yang
Senior Associate, Market Access and Outcomes Strategy
Jonathan Graham
Director, Health Economics
Anne Heyes
Head, Market Access and Outcomes Strategy, Europe
Christopher Graham
Senior Director, Health Economics
Carla DeMuro
Executive Director, Patient-Centered Outcomes Assessment
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Dawn Odom
Vice President, Head, Biostatistics
Joan Fortuny
Director, Epidemiology
Stephanie Barrows
Senior Director, Market Access and Outcomes Strategy
Donald Stull
Head, Data Analytics and Design Strategy
Katherine Hicks
Director, Health Economics
Kelly Hollis
Vice President, Surveys and Observational Studies

Selected Recent Oncology Publications